Riskpilot← Back to searchSign inGet full accessBtyscience AB
ABActiveOrg 5590959002Smyckegatan 8 1tr Lgh 1102Beauty care and other beauty treatment activities · NACE 9622Est. 20170 employees
Revenue 2024
SEK 616K
-28% vs 2023
EBITDA margin
23.3%
+139% vs 2023
Equity ratio
86.1%
Financial strength
Net profit 2024
SEK 108K
+188% vs 2023
| Revenue | SEK 616K | -28% |
| EBITDA | SEK 143K | +139% |
| Net profit | SEK 108K | +188% |
| Total assets | SEK 239K | +29% |
| Equity | SEK 206K | +50% |
| Employees | 0 | — |
Legal name
Btyscience AB
Org number
5590959002
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
3 januari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är att utföra skönhetsbehandlingar i form av skönhetskorrektur och därmed förenlig verksamhet.
Address
Smyckegatan 8 1tr Lgh 1102
Email
paolo@btyscience.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 135 | 1 574 | 1 528 | 856 | 616 |
| Staff expenses | — | — | −399 | −157 | −74 |
| EBITDA | 197 | −55 | 86 | 60 | 143 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 197 | −55 | 86 | 60 | 143 |
| Net financials | −45 | −9 | −9 | −2 | −0 |
| Profit before tax | 153 | −64 | 78 | 58 | 143 |
| Tax | −0 | −0 | −9 | −20 | −35 |
| Net profit | 153 | −64 | 69 | 38 | 108 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 374 | 284 | 262 | 186 | 239 |
| Equity | 170 | 107 | 100 | 138 | 206 |
| Long-term debt | 74 | 0 | — | — | — |
| Short-term debt | 129 | 178 | 162 | 48 | 33 |
| Total debt | 203 | 178 | 162 | 48 | 33 |
EBITDA margin
23.3%
This company
15.8%
Market median
+47% vs market
20202024
Equity ratio
86.1%
This company
38.2%
Market median
+125% vs market
20202024
Return on equity
52.5%
This company
18.4%
Market median
+185% vs market
20202024
Net profit margin
17.6%
This company
8.1%
Market median
+117% vs market
20202024
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
VS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Btyscience AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Viktoria Sandra Lindelöf | Deputy Chief Executive Officer | 0 companies |
| Bryan Hans Leif Eriksson | Board of Directors | 0 companies |
| Paolo Greger Nilsson | Chairman | 0 companies |
| Gustav Erik Nilsson | Deputy Board Member | 0 companies |
| Gustav Erik Nilsson | Deputy Board Member | 0 companies |